Charmeil named Sanofi vaccines head

Sanofi-Aventis has named Olivier Charmeil as its new senior VP of vaccines. Charmeil previously covered the Asia-Pacific and Japan regions in the company's pharmaceutical division, which Sanofi CEO Christopher Viehbacher says is an asset to vaccines, as it focuses on emerging markets. The leadership change will occur Jan. 1, as Wayne Pisano steps down. Sanofi release | Article

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.